Healthway Medical Overcomes Demanding Cold Chain Requirements to Distribute COVID-19 Vaccines in Singapore

Amid the increased demand by the population for an alternative to mRNA vaccines, stringent cold chain requirements, and the Special Access Route established by the Health Sciences Authority, Healthway Medical managed to bring the Sinopharm SARS-CoV-2 vaccine into Singapore.

Challenge

The emergence of the pandemic meant that there was an increased demand in Singapore for cold chain facilities to store and manage the vaccines and along with it, the delivery and, logistics required to support these facilities.

Due to the short timeframe of delivery and quick turnaround services, the customer needed a cold chain business partner with the available capacity, resources, and capabilities to manage the cold chain requirements for the Sinopharm vaccine.

Approach

The priority for us was to plan and manage a three-hour delivery window period for the lifesaving and COVID-19 related diagnostic products. To achieve this, we adjusted the team’s manpower and logistics schedule to cope with the increase of around 30 percent in cold chain deliveries.

We also added another 50 percent more temperature loggers and invested in new radio frequency systems for tracking, monitoring, and managing the internal logistics movement of the products.

Result

We were able to help Healthway Medical Group manage the vaccines’ logistics and deliveries to all their locations and clinics. The successful rollout of the vaccines meant that the population was able to receive their vaccination safely and on time.